Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview
Autore:
Whitlock, JL; Roeske, JC; Dietz, ML; Straus, CM; Hines, JJ; Horwitz, EP; Reba, RC; Rotmensch, J;
Indirizzi:
Univ Chicago, Dept Obstet, Chicago, IL 60637 USA Univ Chicago Chicago IL USA 60637 ago, Dept Obstet, Chicago, IL 60637 USA Univ Chicago, Dept Gynecol, Sect Oncol Radiat & Cellular Oncol, Chicago, IL 60637 USA Univ Chicago Chicago IL USA 60637 & Cellular Oncol, Chicago, IL 60637 USA Univ Chicago, Dept Radiol, Chicago, IL 60637 USA Univ Chicago Chicago IL USA 60637 ago, Dept Radiol, Chicago, IL 60637 USA Argonne Natl Lab, Div Chem, Argonne, IL 60439 USA Argonne Natl Lab Argonne IL USA 60439 ab, Div Chem, Argonne, IL 60439 USA
Titolo Testata:
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
fascicolo: 9, volume: 39, anno: 2000,
pagine: 3135 - 3139
SICI:
0888-5885(200009)39:9<3135:RTFTTO>2.0.ZU;2-2
Fonte:
ISI
Lingua:
ENG
Soggetto:
IN-VITRO; RA-224; BI-212; DNA;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Engineering, Computing & Technology
Citazioni:
28
Recensione:
Indirizzi per estratti:
Indirizzo: Whitlock, JL Univ Chicago, Dept Obstet & Gynecol, Sect Oncol, Chicago, IL 60637 USA Univ Chicago Chicago IL USA 60637 col, Chicago, IL 60637 USA
Citazione:
J.L. Whitlock et al., "Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview", IND ENG RES, 39(9), 2000, pp. 3135-3139

Abstract

Cancer comprises a group of diseases characterized by the uncontrolled growth of abnormal cells that spread from the anatomical site of origin. For many types of cancer, surgery alone has proven inadequate, necessitating a broader approach to treatment incorporating chemotherapy and radiotherapy. Of particular recent interest has been the use of alpha-emitters in the treatment of microscopic carcinoma. The effective application of these materials requires an understanding of the physical and biological bases of radiation therapy. In addition, both radiochemical and radionuclidic purity are essential in all clinical applications. Recent work with the alpha-emitting radionuclide bismuth-212 offers considerable promise in the treatment of microscopic ovarian carcinoma resistant to conventional treatment modalities. Ongoing improvements in methods for its preparation are expected to furtherimprove its therapeutic utility.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 20:01:18